Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders
Weijia Kong, Claudio Vernieri, Marco Foiani, et al.
Pharmacology & Therapeutics (2020) Vol. 209, pp. 107496-107496
Closed Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

A review on the pharmacokinetics of paeoniflorin and its anti-inflammatory and immunomodulatory effects
Yanxi Zhou, Xiaohong Gong, Hong Zhang, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 130, pp. 110505-110505
Open Access | Times Cited: 143
Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential
Wei Zhang, Chengchao Xu, Jichao Sun, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 3, pp. 1019-1040
Open Access | Times Cited: 110
Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota
Shurong Ma, Qian Tong, Yuan Lin, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 104
Therapeutic potential of triterpenoid saponin anemoside B4 from Pulsatilla chinensis
Yan-Hong Li, Min Zou, Qian Han, et al.
Pharmacological Research (2020) Vol. 160, pp. 105079-105079
Closed Access | Times Cited: 71
Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR’s cholesterol-decreasing efficacy in patients
Chongming Wu, Ying Zhao, Yingying Zhang, et al.
Journal of Advanced Research (2021) Vol. 37, pp. 197-208
Open Access | Times Cited: 59
A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis
Haitao Chen, Fan Zhang, Jin Zhang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 68
Berberine remodels adipose tissue to attenuate metabolic disorders by activating sirtuin 3
Dan Li, Chao Yang, Jianzhong Zhu, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 5, pp. 1285-1298
Open Access | Times Cited: 46
Analgesic Alkaloids Derived From Traditional Chinese Medicine in Pain Management
Wei Jiang, Mingze Tang, Limin Yang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 29
Berberine inhibits breast carcinoma proliferation and metastasis under hypoxic microenvironment involving gut microbiota and endogenous metabolites
Yanfang Sun, Qianqian Zhou, Fang‐Ming Chen, et al.
Pharmacological Research (2023) Vol. 193, pp. 106817-106817
Open Access | Times Cited: 20
Berberine suppresses bladder cancer cell proliferation by inhibiting JAK1-STAT3 signaling via upregulation of miR-17-5p
Yangyang Xia, Xinguo Hou, Jianfeng Cui, et al.
Biochemical Pharmacology (2021) Vol. 188, pp. 114575-114575
Open Access | Times Cited: 39
Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study
Jie Ming, Xinwen Yu, Xiaoqiang Xu, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 36
Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?
Yunyun Quan, Li Li, Zhujun Yin, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 25
Several Alkaloids in Chinese Herbal Medicine Exert Protection in Acute Kidney Injury: Focus on Mechanism and Target Analysis
Yixin Rui, Sheng Li, Fei Luan, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 25
Traditional Chinese Medicines as Effective Reversals of Epithelial-Mesenchymal Transition Induced-Metastasis of Colorectal Cancer: Molecular Targets and Mechanisms
Hongzhang Ge, Xu Chao, Haitao Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
Berberine protects mice against type 2 diabetes by promoting PPARγ-FGF21-GLUT2-regulated insulin sensitivity and glucose/lipid homeostasis
Yi Chen, Qi Li, Shiwei Zhao, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115928-115928
Open Access | Times Cited: 13
Berberine ameliorates vascular dysfunction by downregulating TMAO-endoplasmic reticulum stress pathway via gut microbiota in hypertension
Zhichao Wang, Yijia Shao, Fang Wu, et al.
Microbiological Research (2024) Vol. 287, pp. 127824-127824
Open Access | Times Cited: 5
Berberine Ameliorates Subarachnoid Hemorrhage Injury via Induction of Sirtuin 1 and Inhibiting HMGB1/Nf-κB Pathway
Xianghua Zhang, Lei Peng, Jing Zhang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 36
Recent advances for alkaloids as botanical pesticides for use in organic agriculture
Yuxiang Wu, Dan Ren, Cheng Gao, et al.
International Journal of Pest Management (2021) Vol. 69, Iss. 3, pp. 288-298
Closed Access | Times Cited: 29
Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease
Rou Tang, Rui Li, He Li, et al.
ACS Nano (2021) Vol. 15, Iss. 11, pp. 17016-17046
Closed Access | Times Cited: 29
Berberine Improves Vascular Dysfunction by Inhibiting Trimethylamine-N-oxide via Regulating the Gut Microbiota in Angiotensin II-Induced Hypertensive Mice
Zhichao Wang, Fang Wu, Qianbing Zhou, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 22
Berberine regulates mesangial cell proliferation and cell cycle to attenuate diabetic nephropathy through the PI3K/Akt/AS160/GLUT1 signalling pathway
Wei‐Jian Ni, Ximei Guan, Jing Zeng, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 4, pp. 1144-1155
Open Access | Times Cited: 20
Berberine enhances the function of intestinal stem cells in healthy and radiation-injured mice
Siyu Tu, Yujun Huang, Hefei Tian, et al.
International Immunopharmacology (2024) Vol. 136, pp. 112278-112278
Closed Access | Times Cited: 4
Comparative drug-drug interactions of berberine and astragaloside IV in normal and type 2 diabetes mellitus rats based on UPLC-QqQ-MS/MS
Yan Lei, Jiaqi Xie, Zhongshui Xie, et al.
Acta Materia Medica (2025) Vol. 4, Iss. 1
Open Access
Berberine Inhibited SASP-Related Inflammation through RXRα/PPARγ/NEDD4 Pathway in Atherosclerosis
Yinghong Zheng, Jiayuan Kou, Xi Gao, et al.
The American Journal of Chinese Medicine (2025), pp. 1-33
Closed Access
Berberine partially ameliorates cardiolipotoxicity in diabetic cardiomyopathy by modulating SIRT3‐mediated lipophagy to remodel lipid droplets homeostasis
Wenxian Chen, Tongzhu Jin, Yilin Xie, et al.
British Journal of Pharmacology (2025)
Closed Access
Page 1 - Next Page

Scroll to top